Advocates for Human Potential, Inc.

A Bureau of Justice Assistance (BJA) funded program provided by Advocates for Human Potential, Inc. (AHP)
in partnership with Treatment Alternatives for Safe Communities (TASC) and AdCare Criminal Justice Services (ACJS).

 

See it now! 

Prison/Jail Medication Assisted Treatment Re-entry Programs


 

 

Read it now!
Prison/Jail Medication Assisted Treatment Manual

Once you've seen the video, read the details of these exemplary programs.




 

RSAT, take note!

All RSAT programs should follow Pennsylvania Department of Corrections' lead.

"The PA DOC will no longer do business with service providers who do not, at all levels, support the use of Medication Assisted Treatment"
Source: PA DOC MAT Expansion Plan, p. 8




What Inmates Tell us About RSAT





RSAT Jail Program Tour






Everything you need to know about your state's health insurance opportunities

Save the date,
July 25-27, 2016



5th annual RSAT Workshop, Providence, Rhode Island 
Promising Practices, Useful Studies, and News You Can Use:
  • Important Answers on Medicaid for Transitioning Inmates

    The Center for Medicaid and CHIP Services (CMCS) has issued guidance to states on Medicaid inmate eligibility, enrollment and coverage policy. This letter with attached Questions and Answers (Qs & As) describes how states can better facilitate access to Medicaid services for individuals transitioning from incarceration to their communities. The letter is available online on Medicaid.gov at http://www.medicaid.gov/federal-policy-guidance/federal-policy-guidance.html

  • Injected Naltrexone for Justice Involved Opioid Addicts Compared to Treatment as Usual

    New study examined 153 justice-involved opioid addicts at five sites in four major cities provided monthly injections of naltrexone (Vivitrol) and compared them to 155 who were referred to treatment as usual, counseling and community treatment programs. After six months of injections, 43% of the former group relapsed compared to 64% of those without the shots. Also the former who relapsed managed to stay drug free twice as long as the comparison group. One year after treatment ended, relapses were equivalent. There were more drug overdoses in the non-naltrexone group. The take away: The medication facilitated recovery, but addicts need more than six months of shots and treatment to make a long term difference. However, in regard to medications for opioid treatment, as one researcher concluded: "Right now, there's no debate or argument that going on medications is a better approach. If you're not using medications, you're not really practicing effective evidence-based medicine."

  • Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomized,open-label trial

    This study compared inmates who continued methadone while incarcerated and those who were detoxed and not allowed to continue. More of the former, not surprisingly, continued methadone upon release. More of the latter continued using illicit opioids. Both groups reported drug overdoses and one of the released inmates that had been maintained on methadone died of an overdose after release.

  • Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers — California, 2012

    This assessment of prison HIV opt-out screening is the first known to evaluate the full HIV continuum of care outcomes, including opt-out screening during the medical assessment at entry, linkage to and retention in care, ART response during incarceration, and continuity of care and viral suppression after release to the community.

  • Understanding and Detecting Prescription Drug Misuse and Misuse Disorders

    This drug court fact sheet describes prescription drug misuse and provides information on the most commonly misused and addictive prescription drugs; the extent and consequences of misuse; side effects and toxicity; characteristics of those who are most likely to misuse prescription drugs, signs and symptoms of misuse and ways to identify and treat those who may have developed a drug use disorder, including a section on medication-assisted treatment of opioid use disorder.

  • New, Screening and Assessment of Co-Occurring Disorders in the Justice System

    Among broader discussion, reviews instruments for screening and assessing co-occurring disorders that can be used in jails and prisons at both intake and discharge.

  • Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update

    This readable SAMHSA Advisory Paper provides the latest objective information on the use of Buprenorphine in opioid use disorder treatment, including a breakdown of the different brands of buprenorphine and naloxone medication currently on the market. Briefly compares therapies using Buprenorphine/Nalaxone with Methadone.

  • How Medicaid Enrollment of Inmates Facilitates Health Coverage After Release

    Describes how states are saving millions by assisting inmates sign up for health insurance, both in states that have expanded Medicaid and those that have not.

  • Gender differences in HIV risk behaviors in individuals recently released from prison

    Approximately eight million individuals are released from U.S correctional facilities each year and are at increased risk for HIV. This study examine the HIV risk behaviors of inmates post release and found women at higher risk. The take away is that RSAT programs for women should include gender specific interventions to reduce risky drug related and sex related behaviors immediately following release. The study found, for example, that women’s risk was not solely attributable to engaging in transactional sex, but rather were related to other underlying differences between men and women.

  • Treatment in Secure Corrections for Serious Juvenile Offenders

    A practice profile of programs for serious violent and chronic juveniles offenders in secure facilities, including meta-analysis outcomes and costs.

  • The adverse childhood experiences (ACES) survey

    This toolkit can be used to help staff interview female prisoners on adverse childhood experiences that negatively impact on rehabilitation and health. As one woman suffering from trauma explains, the toolkit transformed her from a self-perceived damaged person full of blame and shame to a trauma survivor, able to protect her children and stop the cycle that was her family legacy.

  • Promising Practices Archive

    The promising practices archive houses useful resources for the RSAT community.



 
Participate in our forum!

Why should prisons or jails provide medications, i.e. drugs, to addicted inmates who are now off drugs, some for the first time in years?